AI Summary
5 min readThe morning after Big Tech’s earnings deluge, the dominant story is not profit beats but the sheer scale of AI spending—and a quiet but real threat to Nvidia’s monopoly on the chips powering it all. Alongside that, the Trump administration has cut roughly $500 million in federal funding for mRNA vaccine development, a move that experts say could cede American leadership in a transformative technology.
The hyperscalers are building their own chips
Four of the five biggest tech companies—Alphabet, Meta, Microsoft, and Amazon—all reported quarterly earnings that beat expectations. But the headline that matters for the semiconductor world is that they are all still spending enormous sums on AI infrastructure. The single biggest line item in that bill is chips, and that has made Nvidia the most valuable company on earth.
Yet the hyperscalers are not content to remain Nvidia’s captive customers. Chris Miller, author of Chip War, notes that these companies have been stepping up investments in their own custom silicon. The motivation is twofold: they want alternatives to Nvidia, and they want chips specialized to their own needs. Google and Amazon are already offering their AI processors to outside customers, including Anthropic and Meta, which is also building its own chips.
Continue reading the full summary in the app — free to try.
Read Full Summary →Free • No credit card required
Never miss an episode of Marketplace Morning Report
Get every new episode summarized in your inbox — free, ~5 minutes to read.
No spam. Unsubscribe anytime.
What you'll learn
- 1 (01:04) **Big Tech Earnings and AI Spending** - Apple, Meta, Microsoft, and Amazon all beat quarterly expectations while continuing massive AI investments.
- 2 (01:34) **Chipping Away at Nvidia’s Dominance** - Other tech giants are building custom chips to reduce reliance on Nvidia, though demand is so high that there’s room for everyone.
- 3 (03:02) **Oil Prices Spike on Iran Tensions** - A brief market update: crude oil jumps after Axios reports President Trump is being briefed on military options in Iran.
- 4 (04:55) **HHS Cuts $500 Million in mRNA Vaccine Funding** - The Department of Health and Human Services is terminating funding for 22 mRNA vaccine projects, raising concerns about U.S. leadership in a transformative technology.
- 5 Standout Quotes
- 6 (02:45) “I don’t really care who’s winning or losing right now. I think it’s the wrong question. The right one is whether these companies can build capacity fast enough.” — Stacy Razgon, Bernstein Research
- 7 (06:36) “It is true that people can get these vaccines and get infected again, but what they’re really being protected against is severe disease, hospitalization, deaths and that was so important.” — Dr. William Moss, Johns Hopkins University
+ Full timestamped outline available in the app
Guests on this episode
Show Notes
It’s Big Tech week on Wall Street. Quarterly results from Alphabet, Meta, Microsoft, and Amazon all beat expectations. And shocker: They’re all still spending a lot on AI. One of the biggest expenses is chips. That’s made Nvidia the most valuable company in the world. Now, other Big Tech companies want to get in on that action. Then, the Trump administration has wound down funding for mRNA vaccine development. We’ll explore the impacts.
More from this podcast
Marketplace Morning Report →